We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
3Symmons, DPM, Barrett, EM, Bankhead, CR et al. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol1994; 33: 735–39.CrossRefGoogle ScholarPubMed
4
4Engel, A, Roberts, J, Burch, TA. Rheumatoid arthritis in adults: United States, 1960–1962. Vital & Health Statistics. Department of Health, Education and Welfare series 11, no. 17. Washington, DC: US Government Printing Office, 1966.Google Scholar
5
5Nesher, G, Moore, TL, Zuckner, J. Rheumatoid arthritis in the elderly. J Am Geriatr Soc1991; 39: 284–94.CrossRefGoogle ScholarPubMed
6
6O'Callaghan, JW, Brooks, PM. Disease modifying agents and immunosuppressive drugs in the elderly. Clin Rheumatol Dis1986; 12: 275–89.CrossRefGoogle ScholarPubMed
7
7Kean, WF, Anastassiades, TP, Dwosh, IL et al. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly. J Am Geriatr Soc1982; 30: 94–100.CrossRefGoogle ScholarPubMed
8
8Kean, WF, Bellamy, N, Brooks, PM. Gold therapy in the elderly rheumatoid arthritis patient. Arthritis Rheum1983; 26: 705–11.CrossRefGoogle ScholarPubMed
9
9Kirwan, JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engt J Med1995; 333: 142–46.CrossRefGoogle ScholarPubMed